Financial results to be released before
market open; Conference call to be conducted at 11:00 am ET
PHOENIX, Nov. 9, 2022
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report
financial results for its third quarter 2022, ended September 30, 2022, before the market open on
Monday, November 14, 2022. The
Company has scheduled a conference call that same day, Monday, November 14, 2002, at 11:00 am ET, to review the results.
Third Quarter 2022 Conference Call Details
Date and Time: Monday, November
14, 2022, at 11:00 am ET
Call-in Information: Interested parties can access the
conference call by dialing (844) 308-3351 or (412) 317-5407.
Live Webcast Information: Interested parties can access
the conference call via a live webcast, which is available in the
Investor Relations section of the Company's website at
http://senestech.investorroom.com/.
Replay: A teleconference replay of the call will be
available for seven days at (877) 344-7529 or (412) 317-0088,
replay access code 9489792. A webcast replay will be available in
the Investor Relations section of the Company's website at
http://senestech.investorroom.com/ for 90 days.
About SenesTech
We are "The Pest Control
Difference" for the 21st century. We are rodent fertility control
specialists fueled by our passion to create a healthy environment
by virtually eliminating rodent pest populations. We keep an
inescapable truth in mind: 2 rats and their descendants can be
responsible for the birth of up to 15,000 pups in a year. We
invented ContraPest , the only U.S. EPA-registered
contraceptive for male and female rats. ContraPest
fits seamlessly into all integrated pest management programs,
greatly improving the overall goal of effective rat management. We
strive for clean cities, efficient businesses, and happy households
– with a product that was designed to be effective and sustainable
without killing rats. At SenesTech , we don't just
eliminate rats. We make a better world.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement
The foregoing paragraphs contain forward-looking statements that
involve estimates, assumptions, risks and uncertainties. Any
statements about our expectations, beliefs, plans, objectives,
assumptions or future events or performance are not historical
facts and may be forward-looking. "Forward-looking statements" may
be preceded by words such as "may," "future," "plan" or "planned,"
"will," "should," "expected," "anticipates," "continue,"
"eventually," "believes," or "projected." Forward-looking
statements include statements concerning the potential impact and
effects of the COVID-19 pandemic on the Company's business, results
of operations and financial performance; any measures the Company
has and may take in response to COVID-19 and any expectations the
Company may have with respect thereto; the Company's strategy and
target marketing and markets; continuing the Company's vision;
expected benefits of the Company's initiatives and continuation of
those initiatives; deployment of the Company's product; the
continuation or expansion of the use of ContraPest; demand for
ContraPest; the Company's expectation regarding costs, expenses and
cash and continuing its cost improvement plan; future financial
results; and the Company's execution of its strategic business
plan.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-third-quarter-2022-financial-results-on-monday-november-14-2022-301673480.html
SOURCE SenesTech, Inc.